.png)
-
i-SENS is committed to improve human healthProviding integrated diabetes solutions to more than 110 countries around the world.
-
-628.jpg)
-27.jpg)
i-SENS is committed to improve human healthProviding integrated diabetes solutions to more than 110 countries around the world.
About Us
i-SENS (Jiangsu) Co., Ltd. was founded in 2014 with total investment of 55 million U.S. dollars and covering area of about 3.79 acre, and it was invested by the KOSDAQ listed enterprise i-SENS Inc., who provides integrated diabetes solutions to more than 100 countries in the world.
-
55million
A total investment of 55 million USD
-
2000+
Serving more than 2,000 level hospitals in China
-
21+
More than 20 years of R & D and production in the field of blood glucose
.jpg)
More than 20 years focus on blood glucose
Boasting 266 domestic and foreign patents and technologies, and providing integrated diabetes solutions to more than 100 countries around the world
-667.png)
-
18 Countries
-
15 Countries
-
2 Countries
-
36 countries
-
25 Countries
Major Events
-
2000
● i-SENS headquarter set up in Seoul, Korea
-
2007
● The factory in Wonju, South Korea was completed
-
2008
● i-SENS China Representative Office was established in Shanghai
● CareSens II Blood Glucose Meter was launched in China
-
2010
● CareSens N and C series products were launched in China
-
2014
● i-SENS (Jiangsu) Co., Ltd. was established in Zhangjiagang, Suzhou
-
2015
● CareSens N Premier product was launched in China
● A1careTM HbA1c analyzer was launched in China
-
2018
● Obtained CE, ISO13485 certification
-
2019
● Obtain the medical device manufacturing license
● i·sens 710, i·sens 630, i·sens 631 and i·sens 632 series glucose meters obtain the registration certificates of medical devices
● Products begin production in Zhangjiagang factory
-
2022
● CareSens C BT, CareSens II Plus and CareSens NoCoding 1 Plus series products obtain the qualification examination of NMPA
-44.jpg)
